Is GILD (Gilead Sciences, Inc.) Halal or Haram?

Based on our AAOIFI-standard shariah screening, GILD is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (15.37% vs ≤33% threshold), interest income ratio (0.00% vs ≤5% threshold), and cash & securities ratio (6.63% vs ≤33% threshold).

Gilead Sciences, Inc. is a major biopharmaceutical company globally recognized for its life-saving medical treatments. Its core portfolio addresses critical unmet medical needs, featuring flagship HIV/AIDS drugs like Biktarvy and Descovy, alongside liver disease treatments such as Epclusa and the COVID-19 antiviral Veklury. For Muslim investors, Gilead presents a compelling opportunity as it successfully passes all AAOIFI shariah screens, earning a Halal status. The company's core business of drug manufacturing is inherently permissible and highly beneficial to society, while its financial practices remain strictly within Islamic guidelines. From an Islamic finance perspective, Gilead's balance sheet is highly compliant and conservative. The company's debt-to-market cap ratio is well-managed at 15.4%, and it relies strictly on its pharmaceutical sales rather than interest-bearing investments, evidenced by its flawless 0.00% interest income ratio. While currently fully compliant, halal investors should continue to monitor Gilead's future acquisitions or financing strategies to ensure its debt levels remain below the 33% threshold. The ongoing expansion of its oncology pipeline, including treatments like Yescarta and Trodelvy, presents a strong, permissible growth avenue to watch. Gilead Sciences, Inc. operates in the Healthcare sector under the Drug Manufacturers - General industry and is headquartered in Foster City, CA, US. The company is led by CEO Daniel O'Day and employs approximately 17,600 people.

GILD was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. GILD passed 4 of these 4 screens.

GILD has negligible interest income, so purification may not be necessary. However, it is always advisable to consult a qualified scholar regarding your specific investment situation.

GILD was last screened on 2026-04-29. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.